Introduction {#sec1_1}
============

Laser in situ keratomileusis (LASIK) is an effective procedure and the surgery of choice in the management of refractive errors. Over the years, LASIK has been proven to be safe, showing high efficacy and predictability, rapid visual recovery and minimal risk of complications. Prior to the advent of excimer laser, radial keratotomy (RK) was widely performed to correct myopic refractive errors \[[@B1]\]. However, RK was not as predictable as LASIK, giving rise to various complications such as undercorrection or overcorrection, unstable vision and late hyperopic shift \[[@B1], [@B2], [@B3]\]. Post-RK correction of refractive errors includes the use of spectacles, fitting of contact lenses, photorefractive keratectomy, piggyback intraocular lenses and LASIK \[[@B4], [@B5], [@B6], [@B7], [@B8]\]. We used a new presbyLasik algorithm that performs an aspheric treatment. It differs from previous central or peripheral presbyLasik profiles because no transitional zones are created. Rather, near vision is restored by creating an elevation within the 3-mm zone, displaying a central depression (fig. [1](#F1){ref-type="fig"}). This modification increases total positive spherical aberrations and the depth of field \[[@B9]\]. Far vision correction is made between the 3.0- and 6.0-mm zone. We report the uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), uncorrected intermediate visual acuity (UIVA), higher order aberrations (Z400, Z311) and patient\'s satisfaction over a follow-up period of 6 months.

Case Report {#sec1_2}
===========

A female presbyopic patient was referred to our clinic. At a younger age, RK was performed on both eyes due to high myopia. She reported glares and halos and various limitations in her daily activities. We proceeded with a presbyLasik correctional approach treating hyperopia and presbyopia in one session. Simulation with multifocal corneal contact lenses for 1 week was performed to rule out a possible visual intolerance and to estimate the refractive outcome. Scheduled eye exams took place on the 1st day, 1st week, 1st month, 3rd month and 6th month after surgery. Corneal topography and wavefront aberrometry were performed using Scheimpflug imaging and Hartmann-Shack aberrometry. Monocular visual outcomes of UDVA, UNVA, corrected distance visual acuity (CDVA) and UIVA were performed using logMar and Snellen charts. UNVA was measured at a distance of 40 cm and UIVA at 80 cm using the Logarithmic Visual Acuity Chart 2000 'New ETDRS'. Results are reported in a 20/20 scale. During the follow-up sessions, we performed a basic routine survey on a scale from 1 to 5. It addressed four specific questions: foreign body sensation, driving, computer and reading experience without spectacles. Flap was created with the Fs laser at 9.0 mm and flap thickness target was 110 µm. Corneal ablation was performed with Technolas 217z. One-sample t test was performed for 12 samples. For one-sample t test, the baseline values were used as reference value of comparison. Statistical significance was defined as p \< 0.05.

Results {#sec1_3}
=======

Baseline manifest refraction spherical equivalent (MRSE) of +1.75 D on the right eye and +0.75 D on the left eye shifted to myopia on both eyes (mean −0.4 ± 1.16 D). UNVA improved significantly. UIVA improved from 20/32 on the right eye and 20/25 on the left eye to 20/25 at 6 months on both eyes. The improvement of UNVA and UIVA was statistically important (one-sample t test, p = 0.0007 and p = 0.0018, respectively; fig. [2](#F2){ref-type="fig"}). CDVA improved from 20/32 in both eyes at baseline to 20/20 on the right eye and 20/25 on the left eye at 6 months (paired sample t test, p = 0.0143; fig. [2](#F2){ref-type="fig"}). UDVA at baseline was 20/50 on the right eye and 20/40 on the left eye and remained stable (one-sample t test, p = 0.11, mean 0.48 ± 0.17). CDVA was better in comparison to the UDVA (fig. [2](#F2){ref-type="fig"}). Z 400 was induced on both eyes and changed from +0.76 to +0.99 µm in the right eye and from +0.45 to +0.67 µm in the left eye. Z 311 changed from −0.64 to −0.18 µm in the right eye and from −0.18 to −0.3 µm in the left eye (fig. [3](#F3){ref-type="fig"}). Corneal Q factor on 30° changed from 2.40 to 1.98 in the right eye and from 1.89 to 1.56 in the left eye. Our patient gave positive scores on the survey regarding her driving, reading and PC working experience after the treatment (one-sample t test, 3.16 ± 0.9, p = 0.03, 3.5 ± 1.3, p = 0.04 and 3.3 ± 1.03, p = 0.02, respectively; fig. [2](#F2){ref-type="fig"}) but gave negative scores regarding foreign body sensations (p = 0.02, 2.66 ± 1.96).

Discussion {#sec1_4}
==========

RK was the treatment of choice for treating myopia in the 80\'s \[[@B1]\]. However, it has been proven to give rise to various complications, mostly unstable vision and hyperopic shift of MRSE \[[@B1], [@B2], [@B3]\]. After LASIK was introduced and established as the treatment of choice, refractive errors after RK were commonly treated in this manner \[[@B4], [@B5], [@B6], [@B7], [@B8]\]. Although LASIK is regarded as a good surgical option following RK, various complications like splitting of the incisions up to the center of the cornea during flap lifting are reported \[[@B10]\]. In our case, we considered it a relative safe approach for our patient. Given the fact that during the RK procedure, a clear zone of 3--4 mm is left behind and that Supracor creates the elevation within the 3-mm zone, we decided to treat presbyopia as well. In the results section, we described the refractive outcome of this approach. LASIK results after RK regarding the UDVA are well documented \[[@B4], [@B7], [@B8]\]. Supracor significantly improved the UIVA and UNVA. It can be debated that this improvement is due to myopic shift of the MRSE, still monovision cannot be achieved with −0.5 D, while further myopia would clearly have a negative effect on UDVA. Induced aberrations can increase the depth of field and improve near vision \[[@B11], [@B12], [@B13]\]. Our patient gave positive scores regarding her daily activities and stated to be almost spectacles free. A direct comparison using the same treatment approach as we did was not possible. Regarding Supracor itself, a similar improvement of UNVA is reported \[[@B9], [@B10], [@B11], [@B12], [@B13], [@B14]\]. Other reports of presbyopia treatments using corneal inlays reported good results in UNVA and UDVA and suggested that manipulation within the 3.0-mm clear zone with the Fs Laser is safe \[[@B15]\]. In conclusion, we would like to introduce a new correction approach for post-RK presbyopic patients that improves UNVA, UIVA and quality of life. UDVA remained stable and CDVA was better after treatment. In our patient, it was efficient and safe (fig. [1](#F1){ref-type="fig"}; fig. [3](#F3){ref-type="fig"}), and although results seem promising, applying multifocal profiles on an already aberrated cornea can result in a disaster. A simulation with multifocal corneal contact lenses prior to surgery is mandatory, and the instability of the cornea after RK has to be taken seriously under consideration before proceeding \[[@B12]\]. Prospective studies should be carried out in order to evaluate safety and efficacy of presbyLasik treatments following RK.
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![Scheimpflug corneal topography through all follow-ups displaying elevation within the 3-mm zone.](cop-0005-0423-g01){#F1}

![Visual outcomes of UIVA, UNVA and UDVA versus CDVA and scores provided from the patient regarding her daily activities (near reading, driving and computer working experience) and foreign body sensations, after Supracor corneal enhancement. Comparison of daily activities with baseline scores (one-sample t test, 3.16 ± 0.9, p = 0.03, 3.5 ± 1.3, p = 0.04, 3.3 ± 1.03, p = 0.02 and 2.66 ± 1.96, p = 0.02, respectively).](cop-0005-0423-g02){#F2}

![Change of point spread function in fovea at baseline and at 6 months, and anterior segment OCT of both eyes at 6 months after Supracor.](cop-0005-0423-g03){#F3}
